Concepedia

Natalie E. R. Beveridge

NE

Statistics

Publications

8

Citations

719

H-Index

8

Active since

2007

Affiliations

University of Oxford(Current)

Jenner Institute

Churchill Hospital

National Institute of Allergy and Infectious Diseases

London School of Hygiene & Tropical Medicine

Natalie E. R. Beveridge is an author at University of Oxford specializing in vaccinology, immunology, and infectious diseases.

ORCID

Publications per year

2007–2011

8

Publications

8

Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional <i>Mycobacterium tuberculosis</i>‐specific CD4<sup>+</sup> memory T lymphocyte populations

Natalie E. R. Beveridge, David A. Price, Joseph P. Casazza et al. · European Journal of Immunology · 2007 · 225 citations · Full text

, , +17

Establishment of an Aerosol Challenge Model of Tuberculosis in Rhesus Macaques and an Evaluation of Endpoints for Vaccine Testing

S. Sharpe, Helen McShane, Michael J. Dennis et al. · Clinical and Vaccine Immunology · 2010 · 128 citations · Full text

, , +17

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in <i>Mycobacterium tuberculosis</i> –infected Individuals

Clare R. Sander, Ansar A. Pathan, Natalie E. R. Beveridge et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 122 citations · Full text

, , +17

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

Ansar A. Pathan, Clare R. Sander, Helen A. Fletcher et al. · PLoS ONE · 2007 · 64 citations · Full text

, , +17

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

Angela M. Minassian, Rosalind Rowland, Natalie E. R. Beveridge et al. · BMJ Open · 2011 · 48 citations · Full text

, , +17

1–5 of 8